Prospekta for ADHD
This study is completed in Russia. It is testing prospekta for ADHD.
Multiple locations, including Bryansk
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Russia. It is testing prospekta for ADHD.
Multiple locations, including BryanskThis study is completed. It focuses on schizophrenia and currently lists study information in Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, the Philippines, Poland, Sweden, Turkey, and the United States.
Multiple locations, including Garden GroveThis study is completed. It focuses on schizophrenia and currently lists study information in Argentina, Brazil, Chile, Croatia, France, Hungary, Japan, Malaysia, the Netherlands, Poland, Romania, Serbia, Singapore, Slovakia, South Korea, Spain, Ukraine, and the United States.
Multiple locations, including BellflowerThis study is completed. It focuses on PTSD and currently lists study information in China.
In FangtingThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In PhiladelphiaThis study is completed. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including Costa MesaThis study is completed in South Korea. It focuses on PTSD.
In SeoulThis study is completed in Israel. It focuses on ADHD.
In Ramat GanThis study is completed. It focuses on depression and currently lists study information in the United States.
In New YorkThis study is enrolling by invitation. It focuses on depression and currently lists participation information in Mexico.
In MexicaliThis study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Spain.
In SalamancaThis study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
In BostonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.